Conference summary and conclusions. A comprehensive approach to predicting and managing mood effects of glucocorticoids.
The discovery of glucocorticoids and their enormous therapeutic benefits led to the use of these compounds as valuable medications for a wide variety of diseases. In 1950 this effort was ushered in by a landmark event-the awarding of the 1950 Nobel Prize in Physiology and Medicine to Drs. Phillip Hench, Edward Kendall, and Tadeus Reichstein. It was Hench who described and researched the successful use of the glucocorticoid, cortisone, and pituitary adrenocorticotrophic hormones to treat rheumatoid arthritis. Significant scientific discovery preceded Hench and colleagues' efforts, but the revolutionary accumulation of discovery in glucocorticoids since then is one of the unique scientific stories in the history of medicine. The scientific conference upon which this volume is based represents an attempt to convene a state-of-the-science meeting on the current understanding and scientific status of this fascinating, far-reaching, and fast-moving field. This last chapter will summarize the exciting presentations of this 2-day conference.
Sternberg
Esther M
EM
National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
Judd
Lewis L
LL
D000339:Affect / Q000187:drug effects* / Q000502:physiology; D005938:Glucocorticoids / Q000266:history / Q000627:therapeutic use*; D049673:History, 20th Century; D006801:Humans; D013315:Stress, Psychological / Q000188:drug therapy* / Q000523:psychology; D013405:Suicide / Q000523:psychology*; D000092864:Suicide Prevention
D005938:Glucocorticoids